0
Skip to Content
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Home
Folder: Science
Back
ALT-100
Pipeline
Folder: About US
Back
Management
Scientific Advisory Board
Board of Directors
Folder: Resources
Back
ROADMAP
News & Press Releases
Publications
Contact Us
KEY ACTIVITIES & PRESS Rebecca Nunn 2/1/22 KEY ACTIVITIES & PRESS Rebecca Nunn 2/1/22

Aqualung Therapeutic’s ALT-100 Antibody Significantly Reduces ARDS Severity in Both Rat and Porcine (Large Animal) Preclinical Models

Aqualung Therapeutic’s ALT-100 Antibody Significantly Reduces ARDS Severity in Both Rat and Porcine (Large Animal) Preclinical Models ByACCESSWIRE Published February 1,

Read More
KEY ACTIVITIES & PRESS Rebecca Nunn 7/22/21 KEY ACTIVITIES & PRESS Rebecca Nunn 7/22/21

Dr. Garcia Grand Rounds at Houston Methodist: A Systems Biology Journey to DAMPen Acute Lung Inflammation

Dr. Garcia Grand Rounds at Houston Methodist: A Systems Biology Journey to DAMPen Acute Lung Inflammation

Read More
KEY ACTIVITIES & PRESS Rebecca Nunn 2/15/21 KEY ACTIVITIES & PRESS Rebecca Nunn 2/15/21

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths LINK TO FULL ARTICLE 2.13.21 Studies: eNAMPT, an inflammation-regulatory protein is now tightly

Read More

OFFICE

Mailing Address
6080 N Pinchot Rd
Tucson, Az 85750

450 Ocean Drive, 1205
Juno Beach, FL 33408

CONTACT

Email: info@aqualungtherapeutics.com
Tel: 312-618-7337 or
919-410-0504